Six companies have been selected to pitch to potential investors at Angels in MedCity’s first presentation event on Thursday 26 February.
The event, to be held at Lloyds Bank’s City of London HQ, follows a series of investor workshops to introduce the life sciences sector to potential investors.
The first companies to present have been chosen by a panel of experts for their high growth potential and scientific quality. Their focuses range from software to perform genome editing to equipment that aids rehabilitation. The companies are seeking to raise between £250k - £1m.
The programme, launched in October 2014, provides impartial advice and information about investing in life sciences with the aim of building up a significant community of angels focused specifically on the sector. Angel investment is a key source of funding for early stage companies but currently only a small proportion is invested in healthcare and life sciences companies, partly due to a low level of understanding of the sector amongst generalist investors. So far over 60 people have attended an Angels in MedCity workshop.
MedCity Executive Chair Dr Eliot Forster says:
“We have world-leading research and infrastructure, but we don’t have the kind of liquidity you find in Boston or San Francisco, which is what you need to create and grow a critical mass of exciting young companies. Angels in MedCity is a key part of our drive to position London as a leading centre for life sciences investment, which will not only support home-grown innovation but attract entrepreneurs from around the world to set up business here.”
All Angels in MedCity events are free to attend
Find out more about attending the pitching event on Thursday 26 February here
Sign up for the next investor workshop on Wednesday 19 March here
Find out how to apply to pitch to the angel investor community at future presentation events here